Expects to File 2013 Form 10-K and Hold Business Update Call on Dec.
30
CHICAGO -- (Business Wire)
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it is in
the final stages of completing its financial restatement. The Company
currently expects to file its Annual Report on Form 10-K for the year
ended December 31, 2013 with the Securities and Exchange Commission
(SEC) after the market closes on December 30, 2014. The 2013 Form 10-K
will include results for the fiscal years ended December 31, 2013 and
December 31, 2012, and restated results for the fiscal year ended
December 31, 2011. The company previously announced on November 12, 2014
that it expected to complete its restatement and related audits, and to
file the 2013 Form 10-K by the middle of December.
Conference Call and Webcast Details
Accretive Health’s management team will host a conference call on
December 30, 2014 at 3:30 p.m. CT (4:30 p.m. ET) to discuss the
restatement and business outlook. To participate, please dial
877-280-4954 (857- 244-7311 from outside the U.S. and Canada) using
conference code number 32430071, or visit the Investor Relations section
of Accretive Health’s web site at www.accretivehealth.com
to access the live webcast. A replay will be available for one week
following the conference call at 888-286-8010 (617-801-6888 from outside
the U.S. and Canada) using conference code number 46013693. A replay of
the conference call will also be available online at www.accretivehealth.com.
About Accretive Health
At Accretive Health, our mission is to partner with healthcare
communities to serve as a catalyst for a healthier future for all. For
more information, visit www.accretivehealth.com.
Safe Harbor
This press release contains forward-looking statements, including the
statements regarding the Company’s ability to file its Annual Report on
Form 10-K for the year ended December 31, 2013. All forward-looking
statements contained in this press release involve risks and
uncertainties. Our actual results and outcomes could differ materially
from those anticipated in these forward-looking statements as a result
of various factors, including the possibility that our ongoing
restatement could have unanticipated consequences and the factors set
forth in the Company’s quarterly report on Form 10-Q for the quarter
ended September 30, 2012, filed with the SEC on November 8, 2012, under
the heading “Risk Factors”. The words “strive,” “objective,”
“anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,”
“plans,” “projects,” “vision,” “would,” and similar expressions are
intended to identify forward-looking statements, although not all
forward-looking statements contain these identifying words. The Company
has based these forward-looking statements on its current expectations
and projections about future events. Although the Company believes that
the expectations underlying any of its forward-looking statements are
reasonable, these expectations may prove to be incorrect and all of
these statements are subject to risks and uncertainties. Should one or
more of these risks and uncertainties materialize, or should underlying
assumptions, projections, or expectations prove incorrect, actual
results, performance, financial condition, or events may vary materially
and adversely from those anticipated, estimated, or expected.
All forward-looking statements included in this press release are
expressly qualified in their entirety by these cautionary statements.
The Company cautions readers not to place undue reliance on any
forward-looking statement that speaks only as of the date made and to
recognize that forward-looking statements are predictions of future
results, which may not occur as anticipated. Actual results could differ
materially from those anticipated in the forward-looking statements and
from historical results, due to the uncertainties and factors described
above, as well as others that the Company may consider immaterial or
does not anticipate at this time. Although the Company believes that the
expectations reflected in its forward-looking statements are reasonable,
the Company does not know whether its expectations may prove correct.
The Company’s expectations reflected in its forward-looking statements
can be affected by inaccurate assumptions it might make or by known or
unknown uncertainties and factors, including those described above. The
risks and uncertainties described above are not exclusive, and further
information concerning the Company and its business, including factors
that potentially could materially affect its financial results or
condition or relationships with customers and potential customers, may
emerge from time to time. The Company assumes no, and it specifically
disclaims any, obligation to update, amend, or clarify forward-looking
statements to reflect actual results or changes in factors or
assumptions affecting such forward-looking statements. The Company
advises investors, however, to consult any further disclosures it makes
on related subjects in our periodic reports that it files with or
furnishes to the SEC.
Contacts:
Accretive Health, Inc.
Investor Relations:
Atif Rahim
312.324.5476
investorrelations@accretivehealth.com
or
Media
Relations:
Brian Pitts
312.475.5921
brian.pitts@hkstrategies.com
Source: Accretive Health, Inc.
© 2024 Canjex Publishing Ltd. All rights reserved.